Bladder wall recurrence of prostate cancer after high-dose-rate brachytherapy - Abstract

PURPOSE: Prostate cancer seeding after needle biopsy has been reported in the perineum, rectal wall, and periprostatic soft tissue.

In this article, we report the results of a localized prostate cancer recurrence in the bladder following protrusion of a single high-dose-rate brachytherapy catheter through the bladder wall at the ultimate site of failure.

METHOD AND MATERIALS: A 62-year-old man with high-risk prostate adenocarcinoma was treated with long-term androgen deprivation therapy, intensity-modulated radiation, and high-dose-rate brachytherapy boost. He developed biochemical recurrence 4 years after treatment, and a CT scan of the pelvis revealed a nodule in the posterior, inferior bladder wall.

RESULTS: Surgical pathology following transurethral resection of tumor within the bladder was consistent with high-grade prostate adenocarcinoma. The patient's prostate-specific antigen level fell to the range of normal postoperatively, and whole body imaging, including a multi-parametric MRI of the prostate with diffusion and spectroscopy, failed to reveal any other sites of disease. Review of the CT scan obtained for dosimetry at the time of brachytherapy demonstrated a lone catheter protruding through the bladder wall at the site of eventual recurrence. The tumor recurred in the bladder 12 months later, once more without evidence of disease within the prostate itself or distantly, and the patient was started on salvage androgen deprivation therapy.

CONCLUSIONS: This case is the first report of prostate cancer recurrence in the bladder wall after brachytherapy and raises questions about prostate cancer biology, brachytherapy technique, and the timing of brachytherapy boost relative to whole pelvic radiotherapy for prostate cancer.

Written by:
Raleigh DR, Hsu IC, Braunstein S, Chang AJ, Simko JP, Roach M 3rd.   Are you the author?
Department of Radiation Oncology, University of California San Francisco, San Francisco, CA; Department of Anatomic Pathology, University of California San Francisco, San Francisco, CA; Department of Urology, University of California San Francisco, San Francisco, CA.  

Reference: Brachytherapy. 2014 Dec 19. pii: S1538-4721(14)00688-6.
doi: 10.1016/j.brachy.2014.11.008

PubMed Abstract
PMID: 25533416 Prostate Cancer Section


Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.